全球犬流感疫苗市场：按疫苗类型、按病毒类型、按分销管道、按地区

预计2024年全球犬流感疫苗市场规模将达18.057亿美元，2024年至2031年复合年增长率为5.1%，2031年将达25.621亿美元。

图：2024 年犬流感疫苗的全球市场占有率（%），依地区划分

犬感冒，俗称犬流感，是由感染犬的流感病毒引起的传染性呼吸道疾病。其特点是咳嗽、流鼻水和发烧。大多数狗会在两到三週内康復，但这种疾病对幼犬、老年犬和感染严重的狗来说可能是致命的。全球犬流感疫苗市场受到各地区该病毒病例数量不断增加的推动。人们对该疾病的认识不断提高，有效疫苗的普及正在支持市场的成长。然而，缺乏强制疫苗接种以及疫苗生产成本高昂正在阻碍市场潜力。总体而言，开发新型疫苗的广泛研究和开发活动为未来几年的市场扩张提供了机会。

市场动态：

随着全球犬流感感染率上升，全球犬流感疫苗市场呈现正成长。研究表明，该病毒在北美、亚太和欧洲的多个国家广泛传播。为了陪伴而饲养的狗的增加，再加上狗舍、狗展和公园里的宠物拥挤，促进了疾病的快速传播。这导致宠物饲主和狗舍对有效预防犬流感疫苗的需求增加。然而，疫苗生产所需的高资本投资以及一些欠发达地区缺乏标准的大规模疫苗接种政策正在阻碍市场成长。此外，COVID-19大流行导致供应链中断的限制也带来了短期挑战。展望未来，随着政府机构、疫苗开发商和兽医共同努力传播对该疾病和疫苗接种价值的认识，新的机会将会出现。

本研究的主要特点

• 本报告对全球犬流感疫苗市场进行了详细分析，以2023年为基准年估计了预测期（2024-2031年）的市场规模（百万美元）和復合年增长率（CAGR%）。
• 它说明了各个细分市场的潜在收益成长机会，并为该市场提供了一系列有吸引力的投资提案。
• 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要见解。
• 它根据公司亮点、产品系列、主要亮点、财务表现和策略等参数，介绍了全球犬流感疫苗市场的主要企业。
• 该报告的见解使负责人和公司经营团队能够就未来的产品发布、升级、市场扩张和行销策略做出明智的决策。
• 全球犬流感疫苗市场迎合了该行业的各种相关人员，如投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
• 透过用于分析全球犬流感疫苗市场的各种策略矩阵，将促进相关人员的决策。

目录

第一章 研究目的与前提

• 研究目标
• 先决条件
• 简称

第二章 市场展望

• 报告说明
  • 市场定义和范围
• 执行摘要
• Coherent Opportunity Map（COM）

第三章 市场动态、法规与趋势分析

• 市场动态
  • 促进因素
  • 抑制因素
  • 机会
• 影响分析
• 市场趋势
• 最近的趋势
• 监管场景
• 製造商收益
• 价格分析
• 收购和合作场景
• 产品发布/核准
• 资金筹措和投资
• PEST分析
• 波特的分析

第四章全球犬流感疫苗市场 - COVID-19 大流行的影响

• 整体影响
• 政府倡议
• COVID-19 对市场的影响

第五章全球犬流感疫苗市场：依疫苗类型划分，2019-2031（百万美元）

• 重组疫苗
• 灭活疫苗
• 其他的

第六章全球犬流感疫苗市场：依病毒类型划分，2019-2031（百万美元）

• H3N8病毒
• H3N2病毒

第七章全球犬流感疫苗市场：依通路划分，2019-2031（百万美元）

• 公共
• 私人的

第八章全球犬流感疫苗市场：按地区划分，2019-2031（百万美元）

第9章 竞争格局

• 公司简介
  • Zoetis Services LLC
  • Merck &Co., Inc.
  • Covetrus
  • CSL Limited
  • Boehringer Ingelheim Animal Health USA Inc.
  • Elanco

第10章分析师建议

第十一章 参考文献与调查方法

The global canine influenza vaccine market is estimated to be valued at USD 1,805.7 Mn in 2024, and is expected to reach USD 2,562.1 Mn by 2031, exhibiting a compound annual growth rate (CAGR) of 5.1% from 2024 to 2031.

Figure. Global Canine Influenza Vaccine Market Share (%), By Region 2024

Canine influenza, commonly known as dog flu, is a contagious respiratory disease caused by influenza viruses that infect dogs. It is characterized by coughing, nasal discharge, and fever. While most dogs recover within 2-3 weeks, it can be fatal for young, old, or critically ill dogs. The global canine influenza vaccine market is driven by the growing cases of the virus across various regions. Increased awareness about the disease and availability of effective vaccination is supporting the market growth. However, lack of mandatory vaccination policies and high costs associated with vaccine production hampers the market potential. Overall, widespread R&D activities to develop new variants of the vaccine provide opportunities for market expansion in the coming years.

Market Dynamics:

The global canine influenza vaccine market is witnessing a positive growth backed by the rising incidence of dog flu infections globally. As per research studies, the virus is widespread across North America, Asia Pacific, and several European countries. Growing dog ownership for companionship coupled with clustering of pets in kennels, dog shows, and parks aids in rapid transmission of the disease. This has boosted the demand for effective vaccination against canine influenza among pet owners and kennels. However, high capital investment required for vaccine production and lack of standard mass vaccination policies in some underdeveloped regions impedes the market growth. Moreover, constraints in supply chain disruptions due to the COVID-19 pandemic presented short-term challenges. Going forward, collaborative efforts from government agencies, vaccine developers, and veterinary practitioners to spread awareness about the illness and value of inoculation will create new opportunities.

Key Features of the Study:

• This report provides an in-depth analysis of the global canine influenza vaccine market, and provides market size (USD Mn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
• It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global canine influenza vaccine market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study Zoetis Services LLC, Merck & Co., Inc., Covetrus, CSL Limited, and Boehringer Ingelheim Animal Health USA Inc., Elanco
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• Global canine influenza vaccine market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global canine influenza vaccine market

Detailed Segmentation-

• By Vaccine Type:
  • Recombinant Vaccines
  • Inactivated Vaccines
  • Others
• By Virus Type:
  • H3N8 virus
  • H3N2 virus
• By Distribution Channel:
  • Public
  • Private
• By Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles:
  • Zoetis Services LLC
  • Merck & Co., Inc.
  • Covetrus
  • CSL Limited
  • Boehringer Ingelheim Animal Health USA Inc.
  • Elanco

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Vaccine Type
  • Market Snapshot, By Virus Type
  • Market Snapshot, By Distribution Channel
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Opportunities
• Impact Analysis
• Market Trends
• Recent Developments
• Regulatory Scenario
• Manufacturer Revenue
• Pricing Analysis
• Acquisitions and Partnerships Scenario
• Product Launches/Approvals
• Funding and Investments
• PEST Analysis
• Porter's Analysis

4. Global Canine Influenza Vaccine Market - Impact of Coronavirus (COVID-19) Pandemic

• Overall Impact
• Government Initiatives
• COVID-19 impact on the market

5. Global Canine Influenza Vaccine Market, By Vaccine Type, 2019 - 2031, (USD Mn)

• Overview
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Recombinant Vaccines
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
• Inactivated Vaccines
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)

6. Global Canine Influenza Vaccine Market, By Virus Type, 2019 - 2031, (USD Mn)

• Overview
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• H3N8 virus
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
• H3N2 virus
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)

7. Global Canine Influenza Vaccine Market, By Distribution Channel, 2019 - 2031, (USD Mn)

• Overview
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Public
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
• Private
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)

8. Global Canine Influenza Vaccine Market, By Region, 2019 - 2031, (USD Mn)

• Introduction
  • Market Share Analysis, By Region, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, For Region, 2020-2031
  • Regional Trends
    • North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2019 - 2031, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Virus Type, 2019 - 2031, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Mn)
    • U.S.
    • Canada
    • Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2019 - 2031, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Virus Type, 2019 - 2031, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
    • Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2019 - 2031, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Virus Type, 2019 - 2031, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Mn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
    • Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2019 - 2031, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Virus Type, 2019 - 2031, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Mn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
    • Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2019 - 2031, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Virus Type, 2019 - 2031, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Mn)
    • GCC
    • Israel
    • Rest of Middle East
    • Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2019 - 2031, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Virus Type, 2019 - 2031, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Mn)
    • North Africa
    • Central Africa
    • South Africa

9. Competitive Landscape

• Company Profiles
  • Zoetis Services LLC*
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Merck & Co., Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Covetrus
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • CSL Limited
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Boehringer Ingelheim Animal Health USA Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Elanco
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies

10. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

11. References and Research Methodology

• References
• Research Methodology
• About us and Sales Contact